Inventor · disambiguated record
Frank Luyten
Also filed as: LUYTEN FRANK · LUYTEN FRANK P
16 granted patents·9 pending applications·123 citations·filing 2000–2018
91Inventor score
Top patents by PatentIndex Score
25 records- 0190US6617161B2Serum-free cell growth mediumUS HEALTH·Filed 2001·Granted Sep 9, 2003·67 cites·20 claims
- 0287US7220558B2Cartilage-derived morphogenetic proteinsUS HEALTH·Filed 2003·Granted May 22, 2007·13 cites·6 claims
- 0383US7485310B2Use of CXCL6 chemokine in the prevention or repair of cartilage defectsTIGENIX NV·Filed 2004·Granted Feb 3, 2009·24 cites·8 claims
- 0482US7148036B2DNA molecules encoding cartilage-derived morphogenetic proteinsUS HEALTH·Filed 2000·Granted Dec 12, 2006·8 cites·6 claims
- 0574US6884871B2Isolation and use of tissue growth-inducing Frzb proteinUS HEALTH·Filed 2001·Granted Apr 26, 2005·4 cites·10 claims
- 0670US6924367B2Method of modulating tissue growth using Frzb ProteinUS HEALTH·Filed 2001·Granted Aug 2, 2005·3 cites·1 claims
- 0768US9089598B2Method of treating connective tissue defect using chondrocytes selected for phenotypic stabilityLUYTEN FRANK·Filed 2008·Granted Jul 28, 2015·1 cites·3 claims
- 0867US2007053991A1Cartilage-derived morphogenetic proteinsLUYTEN FRANK P·Filed 2006·Application pending·0 cites
- 0965US7482114B2In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantationTIGENIX NV·Filed 2003·Granted Jan 27, 2009·1 cites·17 claims
- 1060US7479367B1In vivo assay and molecular markers for testing the phenotypic stability of cell populations and selected cell populations for autologous transplantationTIGENEX N V·Filed 2000·Granted Jan 20, 2009·1 cites·15 claims
- 1160US7371725B2SpondyloarthropathiesLEUVEN K U RES & DEV·Filed 2003·Granted May 13, 2008·1 cites·4 claims
- 1259US7842502B2Use of CXCL6 chemokine for inducing precursor cells into chondrocytesTIGENIX NV·Filed 2008·Granted Nov 30, 2010·0 cites·2 claims
- 1358US7863045B2Isolation of skeletal precursor cellsTIGENIX NV·Filed 2008·Granted Jan 4, 2011·0 cites·8 claims
- 1457US2006149050A1Isolation and method of using tissue growth-inducing FrzbLUYTEN FRANK P·Filed 2006·Application pending·0 cites
- 1554US7049291B2Isolation and method of using tissue growth-inducing Frzb proteinUS HEALTH·Filed 2002·Granted May 23, 2006·0 cites·3 claims
- 1654US2001011131A1DNA molecules encoding cartilage-derived morphogenetic proteinsFiled 2000·Application pending·0 cites
- 1753US7563596B2Method of modulating tissue growth using Frzb proteinUS HEALTH·Filed 2005·Granted Jul 21, 2009·0 cites·20 claims
- 1852US2010068715A1Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage productionTIGENIX NV·Filed 2007·Application pending·0 cites
- 1949US2011256100A1Secreted modular calcium binding protein for intracellular modulation of bone morphogenetic protein signalingUNIV LEUVEN KATH·Filed 2009·Application pending·0 cites
- 2048US2005281788A1Compositions comprising muscle progenitor cells and uses thereofDE BARI COSIMO·Filed 2003·Application pending·0 cites
- 2145US2015307846A1Growth factor cocktail to enhance osteogenic differentiation of mesenchymal cellsUNIV PENNSYLVANIA·Filed 2013·Application pending·0 cites
- 2241US2011158960A1Isolation of precursor cells and their use for tissue repairTIGENIX NV·Filed 2011·Application pending·0 cites
- 2337US11278645B2Engineering functional bone organsUNIV LEUVEN KATH·Filed 2018·Granted Mar 22, 2022·0 cites·20 claims
- 2430US11471492B2Compositions for treatment of osteochondral disordersUNIV LEUVEN KATH·Filed 2016·Granted Oct 18, 2022·0 cites·20 claims
- 2530US2001037017A1DNA molecules encoding cartilage-derived morphogenetic proteinsFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frank Luyten files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →